Mark E. Dmytruk, See remarks at Ginkgo Bioworks Holdings, Inc. (DNA), sold 250,000 shares at $1.50 ($375K) on 2023-05-22, disclosed to the SEC on 2023-05-24.
Scheduled sale ($375k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DNA | SELL | 2025-03-06 | $6K | — | Filing → |
| DNA | SELL | 2025-02-06 | $10K | — | Filing → |
| DNA | SELL | 2025-01-08 | $8K | — | Filing → |